Trinity Life Sciences (PRIVATE.TRINITYLIFE)

Overall impact
B (68)

Commentary

Trinity Life Sciences is a strong overall performer. With a 'B' rating of 68.5 for overall impact (79th percentile compared to all companies), Trinity Life Sciences ranks 30th out of 76 industry peers, behind IMAC, Enzo Biochem, Avedro and 26 others, and ahead of Invitae, Check-Cap, Organovo and 43 others. On top material causes for Trinity Life Sciences's industry (Healthcare Software & Services), Trinity Life Sciences performs well in Improved Mental Health (92.0 score), Quality Lifelong Education (83.5), Child and Maternal Health (93.7) and 5 other causes where it received an 'A' score and performs poorly in Accountable Institutions (19.1 score), Decent, Safe Work Opportunities (36.9), Accountable Institutions (28.2) and 2 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.TRINITYLIFE
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1996
Employees
982
Sector
Industrials
Industry
Professional Services
Sub-industry
Research & Consulting Services
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Massachusetts, United States
Share classes
PRIVATE.TRINITYLIFE
Description
Operator of a life sciences consulting firm focused on providing strategic insights and analysis for precise decision making. The company provides evidence-based solutions such as brand strategy, data management, commercial analytics and market research throughout the product lifecycle. It helps clients highlight market opportunities, helping pharmaceutical, biotech, medical device and diagnostic companies solve their challenging problems through data-driven insights.
Material causes
Ethos considers the following causes material for Trinity Life Sciences, based on its industry sub-industry Research & Consulting Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.